White label ELPA - ClinicalTrials.eu

Study Comparing bb2121 with Standard Treatments for Patients with Relapsed and Refractory Multiple Myeloma

Not recruiting

3 1 1 1
Investigated Diseases:
- Plasma cell myeloma
- Plasma cell myeloma refractory
Investigated Drugs:
+1
Study Comparing Subcutaneous and Intravenous Ocrelizumab for Patients with Multiple Sclerosis

Not recruiting

3 1 1 1
Investigated Drugs:
- Ocrelizumab
Study on Leflunomide and Hydroxychloroquine for Patients with Primary Sjögren’s Syndrome

Not recruiting

2 1 1
Investigated Diseases:
- Sjogren’s syndrome
Investigated Drugs:
- Hydroxychloroquine Sulfate
- Leflunomide
Study on the Effects of Somapacitan and Somatropin in Children with Growth Hormone Deficiency

Not recruiting

3 1 1 1
Investigated Diseases:
- Growth hormone deficiency
Investigated Drugs:
- Somapacitan
- Somatropin
+2
Study on the Effectiveness and Safety of Amlitelimab for Patients Aged 12 and Older with Moderate-to-Severe Atopic Dermatitis Using Topical Corticosteroids

Not recruiting

3 1 1
Investigated Diseases:
- Dermatitis atopic
Investigated Drugs:
Study of Enpatoran in Adults with Systemic Lupus Erythematosus (SLE) and Cutaneous Lupus Erythematosus (CLE)

Not recruiting

2 1
Investigated Diseases:
Investigated Drugs:
- Enpatoran
Long-Term Safety Study of Obefazimod for Patients with Moderate to Severe Ulcerative Colitis

Not recruiting

2 1 1
Investigated Drugs:
- Obefazimod
+5
Study on the Effectiveness and Safety of Alectinib, Entrectinib, and a Drug Combination for Patients with Advanced or Metastatic Non-Small Cell Lung Cancer

Not recruiting

4 1 1 1
Investigated Diseases:
- Non-small cell lung cancer
Study on Atezolizumab with Radiotherapy for Patients with Muscle-Invasive Bladder Cancer

Not recruiting

2 1 1 1
Investigated Diseases:
- Bladder cancer
Investigated Drugs:
- Atezolizumab
Study of PRS-344/S095012 and obinutuzumab combination for patients with solid tumors – First human trial to evaluate safety and effectiveness

Not recruiting

2 1 1 1
Investigated Diseases:
- Neoplasm
Investigated Drugs:
- Prs-344
- Obinutuzumab

Full Name *

e-Mail *

Country Prefix *

Phone Number *

Nationality *

Gender *

Check all consents

Check all consents

I accept the Terms and Conditions and Privacy Policy *

*I accept the Terms and Conditions and Privacy Policy

I consent to receiving commercial information from the Service Operator *

*I consent to receiving commercial information from the Service Operator

I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes *

*I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes

We use cookies